FIELD: medicine.
SUBSTANCE: there is described a new compound - 1-(β-phenylethyl)-4-amino-1,2,4-triazolium bromide exhibiting cardioprotective, anti-ischemic, antihypertensive, antioxidant, protein synthetic and energotropic action.
EFFECT: improved clinical effectiveness.
1 cl, 5 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION "TRIANOL" FOR TREATMENT OF MYOCARDIAL INFARCTION AND ACUTE HEART FAILURE | 2007 |
|
RU2355398C2 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
| AGENT FOR DRUG-INDUCED CORRECTION OF NITROXYDERGIC DISORDERS | 2012 |
|
RU2505297C1 |
| USING 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (HYPERTRIL) AS ACTIVE BASE OF DRUG PREPARATIONS FOR CORRECTING DYSFUNCTIONS OF NITROXYDERGIC SYSTEM OF TARGET ORGANS ACCOMPANYING HOMOCYSTEINEMIA AND ACUTE CEREBROVASCULAR DISORDERS | 2013 |
|
RU2532394C1 |
| WATER-SOLUBLE COMPOSITION, POSSESSIVE PROPERTIES OF CARDIO-PROTECTOR | 2010 |
|
RU2438698C1 |
| HEPATOPROTECTIVE, CARDIOPROTECTIVE AND PLACENTAPROTECTIVE, UTEROLITH AND NO-MIMETIC COMBINED DRUG | 2015 |
|
RU2597785C1 |
| METHOD FOR TREATMENT OF ALCOHOLIC CARDIOMYOPATHY | 2017 |
|
RU2642298C1 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
| METHOD OF CARDIOPROTECTION OF ISCHEMIC AND REPERFUSION INJURIES IN ACUTE MYOCARDIAL INFARCTION | 2019 |
|
RU2712448C1 |
